About Zachary Collins
Form D filings for Ribonaut Therapeutics in 2023 list Zachary Collins as executive officer.
Zachary Collins first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Zachary Collins in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Zachary Collins works with at each company, as listed on that company's latest Form D.
Ribonaut Therapeutics, Inc. · Form D, Jan 4, 2023
ST
Steven Tregay
Director
MD
Matthew Disney
Executive officer and director
LL
Lusong Luo
Director
JD
Jessica Childs-Disney
Promoter